| 1 |
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development |
|
| | Joowon Yim, Hee Hyun Lim, Youngjoo Kwon | | | Archives of Pharmacal Research. 2021; 44(5): 499 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
As a potential treatment of COVID-19: Montelukast |
|
| | Cihan Fidan, Ayse Aydogdu | | | Medical Hypotheses. 2020; 142: 109828 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Treatment of SARS-CoV-2 (COVID-19) cases by the oral administration of montelukast tablets |
|
| | Ameneh Norouzi | | | Bionatura. 2020; 5(4): 1304 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial |
|
| | Kay Wang,Surinder S Birring,Kathryn Taylor,Norman K Fry,Alastair D Hay,Michael Moore,Jing Jin,Rafael Perera,Andrew Farmer,Paul Little,Timothy G Harrison,David Mant,Anthony Harnden | | | The Lancet Respiratory Medicine. 2013; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Anisotropic material behaviours of soft tissues in human trachea: An experimental study |
|
| | Zhongzhao Teng,Olfa Trabelsi,Ignacio Ochoa,Jing He,Jonathan H Gillard,Manuel Doblare | | | Journal of Biomechanics. 2012; 45(9): 1717 | | | [Pubmed] [Google Scholar] [DOI] | |
|
